BioNotebook: Transcept/Purdue, GlycoMimetics, Eagle, Auspex, Intrexon/Medistem, GW Pharmaceuticals, AcelRx
This article was originally published in Scrip
Executive Summary
Purdue drops Transcept's Intermezzo; GlycoMimetics revives IPO; Eagle, Auspex hunt $119m in IPOs; Intrexon buying Medistem for $26m; GW Pharmaceuticals seeks $60m in US; and AcelRx secures credit facility.